Legend Biotech Corp 20-F for FY2023
Legend Biotech Corp (LEGN)
20-F
2024-03-19
For: 2023-12-31
View Original
Added on
April 07, 2026
About this 20-F
Legend Biotech Corp filed this 20-F on March 19, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $285.14M
- up 143.7% from $117.01M a year earlier
- Net loss
- $518.25M
- compared with a net loss of $446.35M a year earlier
- Diluted EPS
- -$1.47
- compared with -$1.40 a year earlier